Intervention not reported
Risk of recurrence and mean time‐to‐recurrence after induction of remission at 2 or 6 months · Participants with a diagnosis of JIA and uveitis who are aged 2 to 18 years old
1 finding from 1 review
- Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis‐associated uveitis 2022 · Cochrane Headline outcomes onlyno estimate extractedStudies not reportedVery low